Mounjaro Manufacturing Locations Mounjaro (tirzepatide), developed by Eli Lilly and Company, is produced across multiple global facilities to meet surging global demand for diabetes and weight loss treatments. Primary manufacturing emphasizes U.S. sites, with expansions underway in Europe, China, and Ireland.

Key U.S. Production Hubs

Eli Lilly heavily invests in domestic capacity amid supply shortages reported into 2026:

  • Lebanon, Indiana : A massive $9 billion "Medicine Foundry" site, with an additional $5.3 billion committed in 2024 for tirzepatide active ingredients. This flagship facility anchors Lilly's strategy.
  • Kenosha County, Wisconsin : $3 billion expansion announced in late 2024 for injectables like Mounjaro pens, adding assembly and packaging; operational hiring boosts local jobs by 750.
  • Research Triangle Park, North Carolina : $1.7 billion plant slated for 2027 startup, focusing on drug substances.

Site| Investment| Focus| Status 135
---|---|---|---
Lebanon, IN| $9B+| API production| Under construction/expanding
Kenosha, WI| $3B| Injectables & packaging| Expansion started 2024
RTP, NC| $1.7B| Drug substances| Expected 2027

International Sites

  • Suzhou, China : $200 million upgrade to the 28-year-old facility for Mounjaro/Zepbound production, supplying China and Europe; total investment nears $2.1 billion. Forum users note some pens labeled "Made in China," though formulation often occurs in the U.S.
  • Ireland : $1.8 billion expansion at two plants for broader capacity.
  • Alzey, Germany : $2.5 billion factory, production by 2027.

Supply Chain & Forum Insights

Reddit discussions (r/Mounjaro, 2025) highlight reliance on Chinese components for some pens/injectors, despite U.S. final assembly—sourcing managers confirm this for cost efficiency. Pharmacists clarify pens may say "Product of China" but are filled/formulated stateside. No full shift away from global sourcing yet, per latest news.

TL;DR : Mostly U.S.-centric (Indiana leads), with growing output in China, Wisconsin, and Europe to hit demand; pens blend global parts.

Information gathered from public forums or data available on the internet and portrayed here.